Recombinant erythropoietin and blood pressure - PubMed (original) (raw)
Recombinant erythropoietin and blood pressure
C Jacquot et al. Lancet. 1987.
No abstract available
Similar articles
- [Effect of recombinant human erythropoietin on hemodynamics in chronic hemodialysis patients].
Tomura S. Tomura S. Nihon Rinsho. 1991 Dec;49 Suppl:695-701. Nihon Rinsho. 1991. PMID: 1808338 Japanese. No abstract available. - Does intravenous erythropoietin lead to an immediate, transient increase in arterial blood pressure in dialysis patients?
Touam M, Perez Oliva J, Zingraff J, Drüeke T. Touam M, et al. Nephron. 1994;67(2):240-1. doi: 10.1159/000187938. Nephron. 1994. PMID: 8072618 Clinical Trial. No abstract available. - [Utility of recombinant human erythropoietin on the anemia of elderly hemodialysis patients].
Ueyama H, Nakahashi H, Sawanishi K, Kuze M, Ono T. Ueyama H, et al. Hinyokika Kiyo. 1992 Dec;38(12):1429-35. Hinyokika Kiyo. 1992. PMID: 1288237 Clinical Trial. Japanese. - The adverse effects of recombinant human erythropoietin therapy.
Wong KC, Li PK, Lui SF, Nicholls MG, Lai KN. Wong KC, et al. Adverse Drug React Acute Poisoning Rev. 1990 Winter;9(4):183-206. Adverse Drug React Acute Poisoning Rev. 1990. PMID: 2088088 Review. No abstract available. - Erythropoietin use in peritoneal dialysis patients.
Zimmerman SW, Johnson CA. Zimmerman SW, et al. Am J Kidney Dis. 1991 Oct;18(4 Suppl 1):38-41. Am J Kidney Dis. 1991. PMID: 1928078 Review.
Cited by
- Erythropoietin: the developing story.
Cotes PM. Cotes PM. Br Med J (Clin Res Ed). 1988 Mar 19;296(6625):805-6. doi: 10.1136/bmj.296.6625.805. Br Med J (Clin Res Ed). 1988. PMID: 3130919 Free PMC article. No abstract available. - Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study.
Pérez-Oliva JF, Casanova-González M, García-García I, Porrero-Martín PJ, Valenzuela-Silva CM, Hernández-Montero T, Lagarde-Ampudia M, Casanova-Kutsareva Y, Avila-Albuerne Y, Vargas-Batista A, Bobillo-López H, Herrera-Valdés R, López-Saura PA; Bioequivalence Study of Erythropoietin Group. Pérez-Oliva JF, et al. BMC Nephrol. 2005 May 23;6:5. doi: 10.1186/1471-2369-6-5. BMC Nephrol. 2005. PMID: 15910687 Free PMC article. Clinical Trial. - [Erythropoietin and hypertension].
Frei U, Nonnast-Daniel B, Koch KM. Frei U, et al. Klin Wochenschr. 1988 Sep 15;66(18):914-9. doi: 10.1007/BF01728954. Klin Wochenschr. 1988. PMID: 3054276 Review. German. - Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock.
Squadrito F, Altavilla D, Squadrito G, Campo GM, Arlotta M, Quartarone C, Saitta A, Caputi AP. Squadrito F, et al. Br J Pharmacol. 1999 May;127(2):482-8. doi: 10.1038/sj.bjp.0702521. Br J Pharmacol. 1999. PMID: 10385249 Free PMC article.